Overview

Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of the Post Marketing Study (PMS) is to evaluate the efficacy and safety profile of nevirapine in the management of the HIV/AIDS in an open environment.
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Nevirapine